Anticoagulation therapy: Preliminary results for the dabigatran-reversal agent idarucizumab

Nat Rev Cardiol. 2015 Aug;12(8):442. doi: 10.1038/nrcardio.2015.93. Epub 2015 Jul 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Benzimidazoles / pharmacology*
  • Blood Coagulation / drug effects*
  • Factor Xa Inhibitors / pharmacology*
  • Humans
  • Male
  • Pyridines / pharmacology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Benzimidazoles
  • Factor Xa Inhibitors
  • Pyridines